Skip to main content

Table 1 General clinicopathological characteristics of patients

From: LncRNA MSTO2P promotes colorectal cancer progression through epigenetically silencing CDKN1A mediated by EZH2

Characteristics

N=56

Age (years)

 ≤ 60

34 (60.71%)

 > 60

22 (39.29%)

Gender

 Male

40 (71.43%)

 Female

16 (28.57%)

Diameter of tumor (cm)

 ≤ 5

26 (46.43%)

 > 5

30 (53.57%)

Pathological grading

 I/II

15 (26.79%)

 III/IV

41 (73.21%)

Distant metastasis

 Negative

27 (48.21%)

 Positive

29 (51.79%)

TNM stage

 I/II

33 (58.93%)

 III/IV

23 (41.07%)